Please try another search
Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation.The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration.
Name | Age | Since | Title |
---|---|---|---|
Carlo Chizzolini | - | - | Member of Scientific Advisory Board |
Jean-François Bach | - | - | Member of Scientific Advisory Board |
Bernard Malissen | - | - | Member of Scientific Advisory Board |
Alain Fischer | - | - | Member of Scientific Advisory Board |
Frédéric Houssiau | - | - | Member of Scientific Advisory Board |
Jules Hoffmann | - | - | Chairman of Scientific Advisory Board |
Jean-Luc Vandebroek | 52 | 2022 | Non-Executive Director |
Jean Stephenne | - | 2022 | Independent Director |
Revital Rattenbach | - | 2022 | Independent Director |
Yves Sagot | 60 | 2023 | Independent Director |
Jean-François Rax | - | 2022 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review